Phase I/II study of tandem cycles of high-dose chemotherapy followed by autologous hematopoietic stem cell support in women with advanced ovarian cancer-Reference-Cited by-同舟云学术

Phase I/II study of tandem cycles of high-dose chemotherapy followed by autologous hematopoietic stem cell support in women with advanced ovarian cancer

Published:2006-01 Issue:1 Volume:16 Page:57-64
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:Int J Gynecol Cancer

Author:

TIERSTEN A.,SELLECK M.,SMITH D.H.,WERTHEIM I.,KAUFMAN E.,HERSHMAN D.,VAHDAT L.T.,SAVAGE D.G.,MACARTHUR R.B.,HESDORFFER C.

Publisher

BMJ

Subject

Obstetrics and Gynaecology,Oncology

Reference29 articles.

1. Cancer Statistics, 2003

2. Is There a Role for Consolidation or Salvage Radiotherapy after Chemotherapy in Advanced Epithelial Ovarian Cancer?

3. High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer

4. High-dose chemotherapy with autologous bone marrow transplantation in patients with refractory ovarian cancer

5. High-dose melphalan and autologous bone marrow support for treatment of ovarian carcinoma with positive second-look operation

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up;Bone Marrow Transplantation;2012-03-19

2. Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with Autologous Stem Cell Transplant in Refractory Cancer: Pharmacokinetic and Pharmacodynamic Correlates;Clinical Cancer Research;2011-10-25

3. Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma;Bone Marrow Transplantation;2009-08-03

4. High-dose regimens for autologous stem cell transplantation;Hematopoietic Stem Cell Transplantation in Clinical Practice;2009

5. Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma;Bone Marrow Transplantation;2008-09-01